Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New video aims to help seniors with kidney disease make tough choices

NCT ID NCT04347629

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a video decision aid helps older adults with advanced kidney disease plan their future medical care. About 456 patients aged 65 and older will watch a video explaining dialysis, non-dialysis management, and CPR, then record their preferences. The goal is to see if this tool increases advance care planning documentation in medical records compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Advance Care Planning Video Decision Aid
What this could lead to
If successful, this could help older kidney patients make more informed decisions about their care options, potentially improving quality of life and reducing unwanted treatments.
What could go wrong
This is a behavioral intervention study, not a drug trial. The video may not change actual care decisions or outcomes, and results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

456 people

The number who actually took part.

Started

Jun 2021

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients age ≥70 are eligible if they have EITHER Advanced CKD defined as ONE eGFR value ≤ 30 ml/min/1.73m2 in the past 12 months NOT determined to be a result of AKI OR Have a diagnosis of CKD and less than a two-year prognosis from any cause, defined by the clinician answering "NO" to the Surprise Question ("Would you be surprised if this patients died in the next two years?") * Patients age 65-69 are eligible if they have BOTH Advanced CKD defined as ONE eGFR value ≤ 30 ml/min/1.73m2 NOT determined to be a result of AKI AND Have less than a two-year prognosis, defined by the clinician answering "NO" to the Surprise Question ("Would you be surprised if this patients died in the next two years?") * Patients who have not had a nephrology visit in the past 12 months can be recruited from non-Nephrology Clinics per the above eligibility criteria Exclusion Criteria: * listed for kidney transplantation or previous transplant recipient * already on or previously on dialysis (including emergent dialysis) * new patient visit * visually impaired beyond 20/200 corrected * psychological state not appropriate for ACP discussions as determined by the primary nephrologist * cognitive impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Decision AIDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Medical Center

    Boston, Massachusetts, 02118, United States

  • Brigham & Women's Hospital

    Boston, Massachusetts, 02115-6110, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02118-2908, United States

  • Renal and Transplant Associates of New England, PC

    Springfield, Massachusetts, 01107-1381, United States

  • Stanford University

    Palo Alto, California, 94034, United States

  • The University of New Mexico Health Sciences Center

    Albuquerque, New Mexico, 87131-0001, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104-6205, United States

  • University of Washington

    Seattle, Washington, 98195-9472, United States

  • VA Palo Alto Health Care System

    Palo Alto, California, 94034-1290, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.